Syngene FY26 PAT Drops 20% on Margin Pressure

• Syngene reported FY26 revenue of ₹3,739 Cr, up 3% YoY, but PAT before exceptional items declined 20% to ₹380 Cr due to margin compression.
• Operating EBITDA margin contracted to 25% in FY26 from 29% in FY25, impacted by higher staff costs and foreign exchange losses.
• The company expanded its ADC platform capabilities and completed 85 client and regulator audits during the year, reinforcing quality standards.
• Key management changes include Kiran Mazumdar-Shaw transitioning to Executive Chairperson and Siddharth Mittal appointed as incoming MD & CEO.